ImportRefusal LogoImportRefusal

GANTA SIVUNNAIDU

⚠️ High Risk

FEI: 3028067517 • Gajuwaka, Andhra Pradesh • INDIA

FEI

FEI Number

3028067517

📍

Location

Gajuwaka, Andhra Pradesh

🇮🇳

Country

INDIA
🏢

Address

9 - 4 - 285/2 Jagavaniplam, Vizag, Gajuwaka, Andhra Pradesh, India

High Risk

FDA Import Risk Assessment

52.1
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

5
Total Refusals
4
Unique Violations
10/18/2023
Latest Refusal
10/18/2023
Earliest Refusal

Score Breakdown

Violation Severity
75.7×40%
Refusal Volume
28.8×30%
Recency
40.8×20%
Frequency
50.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

754×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

Refusal History

DateProductViolationsDivision
10/18/2023
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
118NOT LISTED
3280FRNMFGREG
508NO 510(K)
Division of Southeast Imports (DSEI)
10/18/2023
61WCY04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/18/2023
62LCY40METRONIDAZOLE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/18/2023
61GCY84NORFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/18/2023
61WCY45FLUCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is GANTA SIVUNNAIDU's FDA import refusal history?

GANTA SIVUNNAIDU (FEI: 3028067517) has 5 FDA import refusal record(s) in our database, spanning from 10/18/2023 to 10/18/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GANTA SIVUNNAIDU's FEI number is 3028067517.

What types of violations has GANTA SIVUNNAIDU received?

GANTA SIVUNNAIDU has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about GANTA SIVUNNAIDU come from?

All FDA import refusal data for GANTA SIVUNNAIDU is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.